SalvaRx Group plc announced audited consolidated earnings results for the year ended 31 December 2015. For the year, the company reported operating loss of £194, 000. Loss before tax from continuing operations loss was £192, 000. Loss for the year attributable to equity holders of the parent was £336, 000 or 0.07 pence per basic and diluted share against £35,024, 000 or 41.1 pence per basic and diluted share a year ago. Basic and diluted loss per ordinary share from continuing operations was 0.04 pence. Net cash outflow from operating activities was £296, 000 against £1,486, 000 a year ago.